Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jun 22 · below the Ichimoku cloud · RSI 26 (oversold) · MACD above its signal
None of the 29 investors followed here reported a position in ALUR in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ALUR trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 3, 2025 | Davin Michael RDirector | Sale at price 1.48 - 1.58 per share. | 3.2K | $4.92K |
| Nov 25, 2025 | Davin Michael RDirector | — | 3.2K | — |
| Nov 11, 2025 | Rtw Investments, L.P.Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 1.67 per share. | 1.86M | $3.10M |
| Nov 4, 2025 | Rtw Investments, L.P.Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 3.35 per share. | 1.49M | $5.00M |
| May 18, 2025 | Gaur ShantanuChief Executive Officer | Purchase at price 3.06 per share. | 8K | $24.48K |
| Apr 15, 2025 | Rtw Investments, L.P.Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 3.35 per share. | 1.49M | $5.00M |
| Mar 27, 2025 | Gaur ShantanuChief Executive Officer | Purchase at price 3.35 per share. | 8K | $26.80K |
| Nov 7, 2024 | Gibbons Brendan MOfficer | — | 306.7K | — |
| Nov 7, 2024 | Buch OjasChief Operating Officer | — | 306.7K | — |
| Nov 7, 2024 | Johns Keith B IiDirector | — | 326.1K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.8 | -13.3 | -42.3 | -0.1 | 5.3 | 463.4 | 7.5 | -67.9 | -23.9 | -50.8 | −58.0% | ||
| 2025 | -45.3 | -45.9 | 0.9 | -26.2 | 12.2 | -8.6 | 14.4 | -21.9 | -5.5 | -9.8 | -16.8 | -20.1 | −88.6% |
| 2024 | -20.1 | 7.4 | -45.5 | 14.9 | -24.9 | -33.9 | -13.8 | -23.4 | -7.0 | 16.3 | -46.7 | 13.2 | −88.5% |
| 2023 | 2.1 | -0.5 | -0.2 | 1.4 | 1.5 | 1.2 | -0.8 | -62.4 | 8.0 | -2.3 | -11.2 | 0.3 | −63.0% |
| 2022 | -0.2 | 0.4 | 0.3 | 0.3 | -0.3 | 0.3 | 0.4 | -0.2 | 0.4 | 1.4 | 0.0 | 0.9 | +3.8% |
| 2021 | 1.3 | -2.4 | 0.7 | -1.1 | -0.2 | 0.8 | 0.2 | -0.2 | -0.4 | −1.3% |
No analyst coverage for this instrument.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
No recent headlines.